Current concepts in the imaging of uterine sarcoma

Abdominal Imaging

Volumn 38, Issue 2, 2013, Pages 397-411

  Tirumani, Sree Harsha ^a,c   Ojili, Vijayanadh ^b   Shanbhogue, Alampady Krishna Prasad ^b   Fasih, Najla ^c   Ryan, John G ^c   Reinhold, Caroline ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Carcinosarcoma; Endometrial stromal sarcoma; Leiomyosarcoma; MRI; Uterine sarcomas

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN; FLUORODEOXYGLUCOSE F 18; TAMOXIFEN;

ABDOMINAL HYSTERECTOMY; ADENOSARCOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CARCINOSARCOMA; DIFFUSION WEIGHTED IMAGING; DISTANT METASTASIS; ECHOGRAPHY; ENDOMETRIAL STROMAL TUMOR; ENDOMETRIUM SARCOMA; HUMAN; IMAGING; LEIOMYOSARCOMA; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; MIXED MULLERIAN TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY; TAXONOMY; UNDIFFERENTIATED CARCINOMA; UNDIFFERENTIATED ENDOMETRIAL SARCOMA; UTERUS SARCOMA;

CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LEIOMYOSARCOMA; SARCOMA; SARCOMA, ENDOMETRIAL STROMAL; UTERINE NEOPLASMS;

EID: 84879466004     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9919-x     Document Type: Article

References (51)

1. Major FJ, Blessing JA, Silverberg SG, et al. (1993) Prognostic factors in early stage uterine sarcoma. A Gynecologic Oncology Group study. Cancer 71(Suppl 4):1702-1709
2. Koivisto-Korander R, Butzow R, Koivisto AM, Leminen A (2008) Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001. Gynecol Oncol 111:74-81
3. Jemal A, Siegel R, Xu J, Ward E (2010) Cancer statistics, 2010. CA Cancer J Clin 260:277-300
4. Abeler VM, Royne O, Thoresen S, et al. (2009) Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients. Histopathology 54:355-364
5. D'Angelo E, Prat J (2010) Uterine sarcomas: a review. Gynecol Oncol 116:131-139
6. Tavassoli FA, Devilee P (eds) (2003) World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press
7. Prat J (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104:177-178
8. Wu TI, Yen TC, Lai CH (2011) Clinical presentation and diagnosis of uterine sarcoma, including imaging. Best Pract Res Clin Obstet Gynaecol 25:681-689
9. Royal College of Pathologists (2011) Standards and datasets for reporting cancers. Dataset for histological reporting of uterine sarcomas. London: Royal College of Pathologists
10. Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I (2009) Clinical management of uterine sarcomas. Lancet Oncol 10:1188-1198
11. Schwartz LB, Zawin M, Carcangui MA, Lange R, McCarthy S (1998) Does pelvic magnetic resonance imaging differentiate among the histologic subtypes of uterine leiomyomata? Fertil Steril 70:580-587
12. Tanaka YO, Nishida M, Tsunoda H, Okamoto Y, Yoshikawa H (2004) Smooth muscle tumors of uncertain malignant potential and leiomyosarcomas of the uterus: MR findings. J Magn Reson Imaging 20:998-1007
13. Cornfield D, Israel G, Martel M, et al. (2010) MRI appearance of mesenchymal tumors of the uterus. Eur J Radiol 74:241-249
14. Kapp DS, Shin JY, Chan JK (2008) Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer 112:820-830
15. Pelmus M, Penault-Llorca F, Guillou L, et al. (2009) Prognostic factors in early-stage leiomyosarcoma of the uterus. Int J Gynecol Cancer 19:385-390
16. Renzulli P, Weimann R, Barras JP, Carrel TP, Candinas D (2009) Low-grade endometrial stromal sarcoma with inferior vena cava tumor thrombus and intracardiac extension: radical resection may improve recurrence free survival. Surg Oncol 18:57-64
17. Nucci MR, Harburger D, Koontz J, Dal Cin P, Sklar J (2007) Molecular analysis of the JAZF1-JJAZ1 gene fusion by RT-PCR and fluorescence in situ hybridization in endometrial stromal neoplasms. Am J Surg Pathol 31:65-70
18. Gandolfo N, Gandolfo NG, Serafini G, Martinoli C (2000) Endometrial stromal sarcoma of the uterus: MR and US findings. Eur Radiol 10:776-779
19. Koyama T, Togashi K, Konishi I, et al. (1999) MR imaging of endometrial stromal sarcoma: correlation with pathologic findings. AJR Am J Roentgenol 173:767-772
20. Fujii S, Kaneda S, Tsukamoto K, et al. (2010) Diffusion-weighted imaging of uterine endometrial stromal sarcoma: a report of 2 cases. J Comput Assist Tomogr 34:377-379
21. Tamai K, Koyama T, Saga T, et al. (2008) The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 18:723-730
22. Furukawa R, Akahane M, Yamada H, et al. (2010) Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: report of three cases and literature review. J Magn Reson Imaging 31:975-979
23. Thomas MB, Keeney GL, Podratz KC, Dowdy SC (2009) Endometrial stromal sarcoma: treatment and patterns of recurrence. Int J Gynecol Cancer 19:253-256
24. Shah JP, Bryant CS, Kumar S, et al. (2008) Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 112:1102-1108
25. Garg G, Shah JP, Toy EP, et al. (2010) Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 118:8-13
26. Silva EG, Deavers MT, Malpica A (2007) Undifferentiated carcinoma of the endometrium: a review. Pathology 39:134-138
27. Rha SE, Byun JY, Jung SE, et al. (2003) CT and MRI of uterine sarcomas and their mimickers. AJR Am J Roentgenol 181:1369-1374
28. Chourmouzi D, Boulogianni G, Zarampoukas T, Drevelengas A (2003) Sonography and MRI of tamoxifen-associated Müllerian adenosarcoma of the uterus. AJR Am J Roentgenol 181:1673-1675
29. Clement PB, Scully RE (1990) Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 21:363-381
30. Szklaruk J, Tamm EP, Choi H, Varavithya V (2003) MR imaging of common and uncommon large pelvic masses. Radiographics 23:403-424
31. Farhat MH, Hobeika EM, Moumneh G, Nassar AH (2007) Uterine mullerian adenosarcoma with sarcomatous overgrowth fatal recurrence within two weeks of diagnosis: a case report. J Med Case Rep 1:103
32. Kim SA, Jung JS, Ju SJ, Kim YT, Kim KR (2011) Mullerian adenosarcoma with sarcomatous overgrowth in the pelvic cavity extending into the inferior vena cava and the right atrium. Pathol Int 61:445-448
33. Kernochan LE, Garcia RL (2009) Carcinoasarcomas (malignant mixed Müllerian tumor) of the uterus: advances in elucidation of biologic and clinical characteristics. J Natl Compr Canc Netw 7:550-557
34. Kanthan R, Senger JL (2011) Uterine carcinosarcomas (malignant mixed Müllerian tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int. doi: 10.1155/2011/470795
35. Teo SY, Babagbemi KT, Peters HE, Mortele KJ (2008) Primary malignant mixed Müllerian tumor of the uterus: findings on sonography, CT, and gadolinium-enhanced MRI. AJR Am J Roentgenol 191:278-283
36. Bharwani N, Newland A, Tunariu N, et al. (2010) MRI appearances of uterine malignant mixed Müllerian tumors. AJR Am J Roentgenol 195:1268-1275
37. Genever AV, Abdi S (2011) Can MRI predict the diagnosis of endometrial carcinosarcoma? Clin Radiol 66:621-624
38. Ohguri T, Aoki T, Watanabe H, et al. (2002) MRI findings including gadolinium-enhanced dynamic studies of malignant, mixed mesodermal tumors of the uterus: differentiation from endometrial carcinomas. Eur Radiol 12:2737-2742
39. Ferguson SE, Tornos C, Hummer A, Barakat RR, Soslow RA (2007) Prognostic features of surgical stage I uterine carcinosarcoma. Am J Surg Pathol 31:1653-1661
40. Huang GS, Chiu LG, Gebb JS, Gunter MJ, et al. (2007) Serum CA125 predicts extrauterine disease and survival in uterine carcinosarcoma. Gynecol Oncol 107:513-517
41. Levy A, Medjhoul A, Caramella C, et al. (2011) Interest of diffusion-weighted echo-planar MR imaging and apparent diffusion coefficient mapping in gynecological malignancies: a review. J Magn Reson Imaging 33:1020-1027
42. Fujii S, Matsusue E, Kigawa J, et al. (2008) Diagnostic accuracy of the apparent diffusion coefficient in differentiating benign from malignant uterine endometrial cavity lesions: initial results. Eur Radiol 18:384-389
43. Namimoto T, Yamashita Y, Awai K, et al. (2009) Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas. Eur Radiol 19:2756-2764
44. Kato H, Kanematsu M, Furui T, et al. (2008) Carcinosarcoma of the uterus: radiologic-pathologic correlations with magnetic resonance imaging including diffusion-weighted imaging. Magn Reson Imaging 26:1446-1450
45. Tsujikawa T, Yoshida Y, Mori T, et al. (2008) Uterine tumors: pathophysiologic imaging with 16α-[18F] fluoro-17β-estradiol and 18F-fluorodeoxyglucose PET - initial experience. Radiology 248:599-605
46. Nagamatsu A, Umesaki N, Li L, Tanaka T (2010) Use of 18F- fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas. Oncol Rep 23:1069-1076
47. Kao YH, Saad U, Tan AE, Magsombol BM, Padhy AK (2011) Fluorine-18-fluorodeoxyglucose PET/CT for the evaluation of suspected recurrent uterine leiomyosarcomas. Acta Radiol 52:463-466
48. FIGO Committee on Gynecologic Oncology (2009) FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 104:179
49. Pecorelli S (2009) Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 105:103-104
50. Seddon BM, Davda R (2011) Uterine sarcomas - recent progress and future challenges. Eur J Radiol 78:30-40
51. Gadducci A, Cosio S, Romanini A, Genazzani A (2008) The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol 65:129-142